No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ICLR240621C360000
- 1.20
- 0.000.00%
15min DelayClose Jun 14 10:29 ET
0.00High0.00Low
1.20Open1.20Pre Close0 Volume10 Open Interest360.00Strike Price0.00Turnover77.92%IV15.28%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry1.20Extrinsic Value100Contract SizeAmericanOptions Type0.0878Delta0.0052Gamma261.11Leverage Ratio-0.4050Theta0.0042Rho22.93Eff Leverage0.0630Vega
Intraday
- 5D
- 1D
News
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,400 Today
Icon (NASDAQ:ICLR) has outperformed the market over the past 15 years by 6.88% on an annualized basis producing an average annual return of 19.66%. Currently, Icon has a market capitalization of $26.3
Here's Why ICON (NASDAQ:ICLR) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to rui
Is Now The Time To Put ICON (NASDAQ:ICLR) On Your Watchlist?
Global Cardiovascular Clinical Trials Market Size To Exceed USD 9.76 Billion By 2033 L a CAGR of 6.18%
Icon PLC | 6-K: Report of foreign private issuer (related to financial reporting)
Icon Price Target Announced at $370.00/Share by Goldman Sachs
Icon Price Target Announced at $370.00/Share by Goldman Sachs
Comments
While ICON's earnings forecast dipped slightly, the consensus price target remains unchanged. Despite the slower expected revenue growth, ICON is still predicted to outperform the wider industry growth.
ICON Public Limited Company (NASDAQ:ICLR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
$AbbVie(ABBV.US$ $Align Technology(ALGN.US$ $Armata Pharmaceuticals(ARMP.US$ $Ault Alliance(AULT.US$ $Becton Dickinson & Co(BDX.US$ $Carmell(CTCX.US$ $Edwards Lifesciences(EW.US$ $National Vision(EYE.US$ $Icon PLC(ICLR.US$ $Lam Research(LRCX.US$ $Molina Healthcare(MOH.US$ $Impinj(PI.US$ $Rimini Street(RMNI.US$ $Silicon Motion Technology(SIMO.US$ $United Rentals(URI.US$ $Warrantee(WRNT.US$
2
Upgrades
• $Marqeta(MQ.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $Northwest Natural(NWN.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $Otis Worldwide(OTIS.US$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake(SNOW.US$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $Eaton(ETN.US$ : Barclays Downgrades to Underweight from Eq...
• $Marqeta(MQ.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $Northwest Natural(NWN.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $Otis Worldwide(OTIS.US$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake(SNOW.US$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $Eaton(ETN.US$ : Barclays Downgrades to Underweight from Eq...
12
1
Upgrades
• $Aptiv PLC(APTV.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $112 (from $108)
• $ASM INTERNATIONAL NV SPON ADR EACH REP 1 ORD SHS(ASMIY.US$ : Barclays Upgrades to Overweight from EqualWeight - PT $425 (from $300)
• $Brighthouse Financial(BHF.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $54 (from $53)
• $Cardinal Health(CAH.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $74 (from $54)
• $CrowdStrike(CRWD.US$ : Goldman...
• $Aptiv PLC(APTV.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $112 (from $108)
• $ASM INTERNATIONAL NV SPON ADR EACH REP 1 ORD SHS(ASMIY.US$ : Barclays Upgrades to Overweight from EqualWeight - PT $425 (from $300)
• $Brighthouse Financial(BHF.US$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $54 (from $53)
• $Cardinal Health(CAH.US$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $74 (from $54)
• $CrowdStrike(CRWD.US$ : Goldman...
11
1
Read more